Is an increased proportion of myofibroblasts a feature of irreversible airway remodeling in patients with chronic asthma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Yes, an increased proportion of myofibroblasts is a key feature of irreversible airway remodeling in patients with chronic asthma. Myofibroblasts are specialized cells that accumulate in the airways of asthmatic patients and contribute significantly to the structural changes that characterize airway remodeling, as noted in a study published in 2019 1. These cells produce excessive amounts of extracellular matrix proteins, particularly collagen and fibronectin, which lead to subepithelial fibrosis and thickening of the airway wall. The transformation of normal fibroblasts into myofibroblasts is stimulated by various inflammatory mediators and growth factors, especially transforming growth factor-beta (TGF-β), which is often elevated in asthmatic airways.

Key Features of Airway Remodeling

  • Increased myofibroblast population
  • Excessive deposition of extracellular matrix proteins
  • Subepithelial fibrosis and thickening of the airway wall
  • Persistent airflow limitation and reduced lung function

This process is part of a pathological repair mechanism that occurs in response to chronic inflammation and repeated epithelial injury. Once established, the increased myofibroblast population and resulting structural changes are difficult to reverse with standard asthma medications, contributing to persistent airflow limitation and reduced lung function in patients with chronic asthma, as discussed in a study from 2013 2. This irreversible component explains why some patients with long-standing asthma develop fixed airway obstruction despite optimal anti-inflammatory treatment.

Clinical Implications

  • Early intervention with inhaled corticosteroids may help prevent the progression of airway remodeling, as suggested by research from 2007 3.
  • New biologic treatments targeting specific phenotypes and endotypes in asthma may offer personalized treatment options for patients with severe refractory asthma, as noted in a 2017 review 4.
  • The importance of fibroblasts and myofibroblasts in asthma-induced airway remodeling has been highlighted in several studies, including one from 2007 5, emphasizing the need for targeted therapeutic approaches.

References

Research

Airway remodeling in asthma and irreversible airflow limitation-ECM deposition in airway and possible therapy for remodeling-.

Allergology international : official journal of the Japanese Society of Allergology, 2007

Research

Anti-IgE and Biologic Approaches for the Treatment of Asthma.

Handbook of experimental pharmacology, 2017

Research

Importance of fibroblasts-myofibroblasts in asthma-induced airway remodeling.

Recent patents on inflammation & allergy drug discovery, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.